Plain-English translation of NCT07218900 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Russia
Phase
Testing effectiveness
Sponsor
AstraZeneca
Enrollment target
~76 participants
Started
November 2025
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.